Literature DB >> 3540098

Gallstone recurrence after medical dissolution. An overestimated threat?

A Lanzini, R P Jazrawi, R M Kupfer, D P Maudgal, A E Joseph, T C Northfield.   

Abstract

We assessed gallstone recurrence rate in 42 patients diagnosed as having complete gallstone dissolution on bile acid therapy. By contrast with most previous studies, this diagnosis was based on ultrasound as well as on radiology, and only patients having their first gallstone recurrence were included in the study. Patients were followed for periods varying from 6 months to 7 years (median 30 months). Eleven patients had recurrences, giving an overall recurrence rate of 26%. A life analysis table was constructed by an actuarial method to compensate for the different lengths of follow-up in individual patients. Corrected recurrence rates by life table analysis were 15%, 21%, 25%, 36%, 45%, 45% and 45% at 1, 2, 3, 4, 5, 6 and 7 years respectively; for the same time intervals, cumulative recurrence rate overestimated the risk of gallstone recurrence (14%, 22%, 31%, 50%, 61%, 79% and 92%). We conclude that previous figures for recurrence rate have been an overestimate; but recurrence rate remains substantial over the first 5 years, and then levels off.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3540098     DOI: 10.1016/s0168-8278(86)80033-2

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  19 in total

1.  Lithotripsy versus cholecystectomy for management of gallstones. A decision analysis by Markov process.

Authors:  A Sonnenberg; G A Derfus; K H Soergel
Journal:  Dig Dis Sci       Date:  1991-07       Impact factor: 3.199

Review 2.  Targets for current pharmacologic therapy in cholesterol gallstone disease.

Authors:  Agostino Di Ciaula; David Q H Wang; Helen H Wang; Leonilde Bonfrate; Piero Portincasa
Journal:  Gastroenterol Clin North Am       Date:  2010-06       Impact factor: 3.806

3.  Medical management of gallstones: a cost-effectiveness analysis.

Authors:  M C Weinstein; C M Coley; J M Richter
Journal:  J Gen Intern Med       Date:  1990 Jul-Aug       Impact factor: 5.128

4.  A retrospective analysis of 3 year's experience of an interdisciplinary approach to gallstone disease including shock-waves.

Authors:  G Heberer; G Paumgartner; T Sauerbruch; M Sackmann; H J Krämling; M Delius; W Brendel
Journal:  Ann Surg       Date:  1988-09       Impact factor: 12.969

5.  Treatment of gall stones. Non-surgical treatments should not be dismissed.

Authors:  A G Lim; R P Jazrawi
Journal:  BMJ       Date:  1995-10-21

6.  Gallstone recurrence after direct contact dissolution with methyl tert-butyl ether.

Authors:  J Pauletzki; J Holl; M Sackmann; M Neubrand; U Klueppelberg; T Sauerbruch; G Paumgartner
Journal:  Dig Dis Sci       Date:  1995-08       Impact factor: 3.199

7.  Gall stone pulverisation strategy in patients treated with extracorporeal lithotripsy and follow up results of maintenance treatment with ursodeoxycholic acid.

Authors:  M Boscaini; M Piccinni-Leopardi; F Andreotti; A Montori
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

8.  Gall stone recurrence and its prevention: the British/Belgian Gall Stone Study Group's post-dissolution trial.

Authors:  K A Hood; D Gleeson; D C Ruppin; R H Dowling
Journal:  Gut       Date:  1993-09       Impact factor: 23.059

9.  Percutaneous cholecystolithotomy: is gall stone recurrence inevitable?

Authors:  J J Donald; S Cheslyn-Curtis; A R Gillams; R C Russell; W R Lees
Journal:  Gut       Date:  1994-05       Impact factor: 23.059

10.  Results of extracorporeal shock wave lithotripsy of gall bladder stones in 693 patients: a plea for restriction to solitary radiolucent stones.

Authors:  A Elewaut; A Crape; M Afschrift; W Pauwels; M De Vos; F Barbier
Journal:  Gut       Date:  1993-02       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.